On December 3, Gelonhui announced that shandong buchang pharmaceuticals (603858.SH) has signed a "Chenfu Yixin Granules Registration Clinical Trial Entrustment Contract" with Beijing Zhuoyue Future International Medical Technology Development Co., Ltd. (called "Beijing Zhuoyue") to entrust Beijing Zhuoyue to complete the registration clinical trial of Chenfu Yixin Granules. The total price of this project's registration clinical trial is 55,338,000.00 yuan (including tax).
This time, the company signed a "Chenfu Yixin Granules Registration Clinical Trial Entrustment Contract" with a third party, which is conducive to expanding the company's pharmaceutical research and development capabilities and scope, to a certain extent, saving time and costs of the company's pharmaceutical clinical trials, and ensuring the smooth progress of the project.
